Shanghai Vitalgen BioPharma Launches Phase I/II Gene Therapy Trial for Parkinson’s Disease
Shanghai Vitalgen BioPharma Co., Ltd, a biopharmaceutical company based in China, has initiated a Phase...
Kintor Pharmaceutical Launches Global Cosmetic Line with Hair Loss Treatment Pyrilutamide
Kintor Pharmaceutical Ltd (HKG: 9939), a biopharmaceutical company based in China, has announced the global...
Suzhou Sanegene Bio Receives NMPA Approval for Clinical Trial of Antihypertensive siRNA Drug
Suzhou Sanegene Bio Inc., a leading RNAi specialist with research and development centers in both...
Shanghai Junshi Biosciences’ HDAC Inhibitor JS125 Clinical Trial Application Accepted by NMPA
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced that the National Medical...
Johnson & Johnson’s Opsumit Faces Generic Competition with Qilu Pharmaceutical’s Entry
Johnson & Johnson (J&J, NYSE: JNJ)’s pulmonary hypertension treatment, Opsumit (macitentan), is set to encounter...
China Isotope & Radiation Corporation Secures NMPA License for Innovative Radiotherapy System
China Isotope & Radiation Corporation (CIRC; HKG: 1763) has announced that it has received a...
Staidson Pharmaceutical Gets NMPA Green Light for Neurotrophic Keratitis Eye Drop Clinical Trial
Staidson (Beijing) Pharmaceutical Co., Ltd (SHE: 300204), a biopharmaceutical company based in China, has announced...
GSK China Vaccine Head Peggy Fung Resigns, Departure Set for Mid-August
Peggy Fung, GSK’s Vice President and Head of Vaccine Business in China, has opted to...
GRIT Biotechnology and Quangang Pharmaceutical Co., Ltd Partner to Develop TIL and IL-2 Combination Therapy
GRIT Biotechnology, a leading cell therapy specialist based in China, has entered into a strategic...
US House Speaker Mike Johnson Revives Possibility of Biosecure Act Vote
US House of Representatives Speaker Mike Johnson has suggested that a vote on the Biosecure...
Shandong Buchang Pharmaceuticals Receives NMPA Approval for BC008-1A Biologic Product Clinical Trial
Shandong Buchang Pharmaceuticals Co., Ltd (SHA: 603858), a pharmaceutical company based in China, has announced...
HOB Biotech Receives NMPA Approval for Clinical Trials of MM09 Sublingual Spray
Jiangsu-based HOB Biotech Group Corp., Ltd (SHA: 688656) has announced that it has received clinical...
Hugo Biotech Partners with Watchmaker Genomics to Develop Infectious Disease Detection Solutions
Hugo Biotech, a biotech company based in Beijing, has entered into a partnership with Watchmaker...
Moderna Partners with Mitsubishi Tanabe for mRNA Vaccine Promotion in Japan
Moderna Inc. (NASDAQ: MRNA), a leading mRNA specialist biotechnology company based in the U.S., has...
Eli Lilly & Co. to Acquire Morphic Holding Inc. in a USD 3.2 Billion Deal
Eli Lilly & Co. (NYSE: LLY), a leading pharmaceutical company in the U.S., has announced...
Roche’s Susvimo Implant Cleared for Relaunch in US After Voluntary Recall
Roche (SWX: RO), the Swiss pharmaceutical giant, has announced the conclusion of the voluntary recall...
Boston Scientific’s FARAPULSE Pulse Field Ablation System Earns NMPA Approval
Boston Scientific Corporation (NYSE: BSX), a leading medical device company in the U.S., has announced...
Ascentage Pharma’s Olverembatinib Receives Marketing Approval from Macau SAR for CML Treatment
Ascentage Pharma (HKG: 6855), a biopharmaceutical company based in China, has announced that it has...
Keymed Biosciences Strikes Licensing Deal with Belenos Biosciences for Global BsAb Rights
Keymed Biosciences Inc. (HKG: 2162), a biopharmaceutical company based in China, has entered into a...
Quantum Hi-Tech Partners with East China Normal University to Establish Advanced Drug Research Lab
Quantum Hi-Tech (China) Biotechnology Co., Ltd, known as ChemPartner (SHE: 300149), has entered into a...